1989
DOI: 10.1083/jcb.109.3.1301
|View full text |Cite
|
Sign up to set email alerts
|

An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.

Abstract: Abstract. A single enzyme found in both Drosophilaand mammalian cells is able to selectively bind and degrade transforming growth factor (TGF)-alpha and insulin, but not EGF, at physiological concentrations. These growth factors are also able to inhibit binding and degradation of one another by the enzyme. Although there are significant immunological differences between the mammalian and Drosophila enzymes, the substrate specificity has been highly conserved. These results demonstrate the existence of a select… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
28
0

Year Published

1990
1990
2007
2007

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 30 publications
1
28
0
Order By: Relevance
“…Insulysin was shown to be identical to an enzymatic activity referred to as ␥-endorphin-generating enzyme, an enzyme that converts ␤-endorphin to ␥-endorphin (␤Ϫendorphin [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] and ␤Ϫendorphin 1-18 (13). In that study GRF, dynorphin B 1-13, dynorphin A 1-17, and pancreastatin 1-49 were shown also to be substrates.…”
mentioning
confidence: 99%
“…Insulysin was shown to be identical to an enzymatic activity referred to as ␥-endorphin-generating enzyme, an enzyme that converts ␤-endorphin to ␥-endorphin (␤Ϫendorphin [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17] and ␤Ϫendorphin 1-18 (13). In that study GRF, dynorphin B 1-13, dynorphin A 1-17, and pancreastatin 1-49 were shown also to be substrates.…”
mentioning
confidence: 99%
“…In addition to its role in regulating insulin degradation, IDE appears to play an important role in the regulation of growth factor levels and cell differentiation (Becker and Roth, 1995;Authier et al, 1996b). There is, in fact, increasing evidence that IDE binds and degrades transforming growth factor, atrial natriuretic peptide, insulin-like growth factors I and II (Garcia et al, 1989;Müller et al, 1992). IDE is also suggested to regulate extracellular level of amyloid b-protein, accumulation of which is an early and necessary step in the pathogenesis of Alzheimer's disease (Qiu et al, 1998;Kurochkin and Goto, 1994).…”
mentioning
confidence: 99%
“…Although its affinity for insulin is especially high, IDE also has several other substrates in vitro, suggesting a potentially wider role for the enzyme in the clearance of hormones and bioactive peptides. Among these peptide substrates are glucagon, insulin-like growth factors I and II (19), atrial natriuretic factor (20,21), transforming growth factor-␣ (22), and, more recently, growth hormone-releasing factor, ␤-endorphin (23), and the amyloid-␤ protein (A␤) (24). Although IDE's physiological involvement in the degradation of most of these peptides remains hypothetical, the metallopeptidase has recently been shown to participate in the clearance of A␤ in the culture medium of the BV2 microglial cell line (25,26).…”
mentioning
confidence: 99%